Literature DB >> 11936355

Immune system and surgical site infection.

S Esposito1.   

Abstract

It is well known that altered host defenses in general can play a significant role in the development of infection in any patient but their role becomes even more important in surgical patients where infections are the result of individual risk factors associated with the patient and other specific factors associated with the surgery itself. Thus all possible factors that can help modify the immune response should be taken into account in order to intervene, whenever possible, with therapies based on defined abnormalities to reduce the rate of post-surgical infections. Many factors associated with the patient have been clearly identified as responsible for a decreased immune response: old age, concomitant diseases (diabetes, renal and liver failure, solid and hematologic neoplasias, malnutrition, autoimmune diseases, AIDS) and concomitant therapies (corticosteroid, cytotoxic agents). Old age can affect both humoral and cell-mediated immune responses. Chronic diseases can be responsible for a reduced primary response or depression of delayed hypersensitivity reactions (renal failure, neoplasias) or changes in leukocyte function (diabetes, leukemia, lymphomas). Malnutrition frequently accompanies diseases such as cancer, chronic and acute pancreatitis, inflammatory bowel diseases. Deficiencies in important vitamins and minerals (B6, A, folate, biotin, riboflavin...) can alter significantly the leukocyte function and immune response. Finally, there appears to be innate immune-suppression following any form of injury which is correlated with its magnitude and can affect any aspect of immunity. This has been well studied both in burn and surgical trauma. Alteration of phagocytosis, opsonization and chemotaxis are typically affected in burns, whereas surgical stress can include some reduction of cell mediated immunity. The best approach today to minimizing post-surgical infections is probably, besides use of antibiotic prophylaxis, to reduce the surgical trauma which consequently reduces the stress response and immune-suppression and to optimize the immune response by maintaining homeostasis through nutritional support.

Entities:  

Mesh:

Year:  2001        PMID: 11936355     DOI: 10.1179/joc.2001.13.Supplement-2.12

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  9 in total

1.  Are immunosuppressive conditions and preoperative corticosteroid treatment risk factors in inguinal hernia repair?

Authors:  M Varga; F Köckerling; F Mayer; M Lechner; R Fortelny; R Bittner; K Borhanian; D Adolf; R Bittner; K Emmanuel
Journal:  Surg Endosc       Date:  2020-06-18       Impact factor: 4.584

2.  Using an Agent-Based Model to Examine the Role of Dynamic Bacterial Virulence Potential in the Pathogenesis of Surgical Site Infection.

Authors:  Vissagan Gopalakrishnan; Moses Kim; Gary An
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-11       Impact factor: 4.730

Review 3.  [Prevention of postoperative infections : Risk factors and the current WHO guidelines in musculoskeletal surgery].

Authors:  Christian Willy; Hayo Rieger; Marcus Stichling
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

4.  Nosocomial infection in sulaimani burn hospital, iraq.

Authors:  A R Qader; J A Muhamad
Journal:  Ann Burns Fire Disasters       Date:  2010-12-31

Review 5.  Liver Trauma: Until When We Have to Delay Surgery? A Review.

Authors:  Inés Cañas García; Julio Santoyo Villalba; Domenico Iovino; Caterina Franchi; Valentina Iori; Giuseppe Pettinato; Davide Inversini; Francesco Amico; Giuseppe Ietto
Journal:  Life (Basel)       Date:  2022-05-06

6.  The laparoscopic approach in abdominal emergencies: has the attitude changed? : A single-center review of a 15-year experience.

Authors:  F Agresta; G Mazzarolo; L F Ciardo; N Bedin
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

Review 7.  A review of the impact of biologics on surgical complications in Crohn's disease.

Authors:  Melissa I Chang; Benjamin L Cohen; Alexander J Greenstein
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

8.  Candida albicans Infections: a novel porcine wound model to evaluate treatment efficacy.

Authors:  Joel Gil; Michael Solis; Alexander Higa; Stephen C Davis
Journal:  BMC Microbiol       Date:  2022-02-04       Impact factor: 3.605

9.  Beyond the Trauma Triad of Death-New Advances in Our Knowledge of Pathophysiology as a Basis for New Perspectives in Support Therapy.

Authors:  Giuseppe Ietto; Caterina Franchi; Gabriele Soldini; Francesco Amico
Journal:  Life (Basel)       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.